These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9112381)

  • 1. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
    Sanyal S; Van Tol HH
    Endocrinology; 1997 May; 138(5):1871-8. PubMed ID: 9112381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the forms of the dopamine D2 receptor expressed in GH4C1 cells.
    Burris TP; Freeman ME
    Proc Soc Exp Biol Med; 1994 Mar; 205(3):226-35. PubMed ID: 8171043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
    Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
    Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of chinook salmon growth hormone promoter activity by the adenosine 3',5'-monophosphate (cAMP)-dependent pathway involves two cAMP-response elements with the CGTCA motif and the pituitary-specific transcription factor Pit-1.
    Wong AO; Le Drean Y; Liu D; Hu ZZ; Du SJ; Hew CL
    Endocrinology; 1996 May; 137(5):1775-84. PubMed ID: 8612514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C regulation of prolactin gene expression in lactotroph cells: involvement in dopamine inhibition.
    Chuang TT; Caccavelli L; Kordon C; Enjalbert A
    Endocrinology; 1993 Feb; 132(2):832-8. PubMed ID: 7678802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that stimulatory dopamine receptors may be involved in the regulation of prolactin secretion.
    Porter TE; Grandy D; Bunzow J; Wiles CD; Civelli O; Frawley LS
    Endocrinology; 1994 Mar; 134(3):1263-8. PubMed ID: 8119166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
    Dorflinger LJ; Schonbrunn A
    Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic adenosine 3',5'-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type.
    Keech CA; Jackson SM; Siddiqui SK; Ocran KW; Gutierrez-Hartmann A
    Mol Endocrinol; 1992 Dec; 6(12):2059-70. PubMed ID: 1337142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants.
    Asghari V; Sanyal S; Buchwaldt S; Paterson A; Jovanovic V; Van Tol HH
    J Neurochem; 1995 Sep; 65(3):1157-65. PubMed ID: 7643093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion.
    Albert PR; Neve KA; Bunzow JR; Civelli O
    J Biol Chem; 1990 Feb; 265(4):2098-104. PubMed ID: 1688845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence of electrical activity and calcium influx-controlled prolactin release on adenylyl cyclase signaling pathway in pituitary lactotrophs.
    Gonzalez-Iglesias AE; Jiang Y; Tomić M; Kretschmannova K; Andric SA; Zemkova H; Stojilkovic SS
    Mol Endocrinol; 2006 Sep; 20(9):2231-46. PubMed ID: 16645040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
    Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
    Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
    Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
    Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary PRL secretion induced by tetraethylammonium is inhibited by dopamine through D2 receptors.
    Wang X; Sato N; Greer MA; Falardeau P
    Mol Cell Endocrinol; 1995 Aug; 112(2):153-7. PubMed ID: 7489818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
    Day RN; Hinkle PM
    Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of VIP on prolactinemia in turkey anterior pituitary cells: role of cAMP second messenger in VIP-induced prolactin gene expression.
    Kang SW; Youngren OM; El Halawani ME
    Regul Pept; 2002 Nov; 109(1-3):39-44. PubMed ID: 12409212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.